Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Operating Expenses (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Operating Expenses for 4 consecutive years, with $11.1 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 55.19% to $11.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.5 million through Dec 2025, down 40.2% year-over-year, with the annual reading at $36.5 million for FY2025, 40.2% down from the prior year.
  • Operating Expenses for Q4 2025 was $11.1 million at Spruce Biosciences, up from $8.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $24.8 million in Q4 2024, with the low at $2.7 million in Q2 2025.
  • Average Operating Expenses over 4 years is $12.9 million, with a median of $12.0 million recorded in 2022.
  • The sharpest move saw Operating Expenses surged 76.29% in 2024, then plummeted 76.88% in 2025.
  • Over 4 years, Operating Expenses stood at $12.1 million in 2022, then grew by 16.03% to $14.1 million in 2023, then soared by 76.29% to $24.8 million in 2024, then plummeted by 55.19% to $11.1 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $11.1 million, $8.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.